Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,962 | -1,584 | -4,140 | -3,195 | -2,460 |
| Depreciation Amortization | 16 | 8 | 16 | 8 | 5 |
| Accounts payable and accrued liabilities | -39 | 97 | -228 | -219 | -302 |
| Other Working Capital | 719 | 88 | -858 | -783 | -728 |
| Other Operating Activity | 425 | 167 | 785 | 696 | 684 |
| Operating Cash Flow | $-2,839 | $-1,224 | $-4,425 | $-3,493 | $-2,801 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -66 | -56 | -34 |
| Investing Cash Flow | $-1 | $-1 | $-66 | $-56 | $-34 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -19 | -2 | 0 | 0 | 0 |
| Financing Cash Flow | $-19 | $-2 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 15,944 | 15,944 | 20,435 | 20,435 | 20,435 |
| End Cash Position | 13,084 | 14,717 | 15,944 | 16,886 | 17,600 |
| Net Cash Flow | $-2,860 | $-1,227 | $-4,491 | $-3,549 | $-2,835 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,839 | -1,224 | -4,425 | -3,493 | -2,801 |
| Capital Expenditure | -1 | -1 | -66 | -56 | -34 |
| Free Cash Flow | -2,841 | -1,225 | -4,491 | -3,549 | -2,835 |